Hubbry Logo
Acetoacetic acidAcetoacetic acidMain
Open search
Acetoacetic acid
Community hub
Acetoacetic acid
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Acetoacetic acid
Acetoacetic acid
Acetoacetic acid
View on Wikipedia
from Wikipedia
Acetoacetic acid
Names
Preferred IUPAC name
3-Oxobutanoic acid[1]
Systematic IUPAC name
3-Oxobutyric acid
Other names
Acetoacetic acid
Diacetic acid
Acetylacetic acid
Acetonecarboxylic acid
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
DrugBank
KEGG
UNII
  • InChI=1S/C4H6O3/c1-3(5)2-4(6)7/h2H2,1H3,(H,6,7) checkY
    Key: WDJHALXBUFZDSR-UHFFFAOYSA-N checkY
  • InChI=1/C4H6O3/c1-3(5)2-4(6)7/h2H2,1H3,(H,6,7)
    Key: WDJHALXBUFZDSR-UHFFFAOYAH
  • O=C(C)CC(=O)O
Properties
C4H6O3
Molar mass 102.089 g·mol−1
Appearance Colorless, oily liquid
Melting point 36.5 °C (97.7 °F; 309.6 K)
Boiling point Decomposes
Soluble
Solubility in organic solvents Soluble in ethanol, ether
Acidity (pKa) 3.58[2]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Acetoacetic acid (IUPAC name: 3-oxobutanoic acid, also known as acetonecarboxylic acid or diacetic acid) is the organic compound with the formula CH3COCH2COOH. It is the simplest beta-keto acid, and like other members of this class, it is unstable. The methyl and ethyl esters, which are quite stable, are produced on a large scale industrially as precursors to dyes. Acetoacetic acid is a weak acid.[3]

Biochemistry

[edit]

Under typical physiological conditions, acetoacetic acid exists as its conjugate base, acetoacetate:

AcCH2CO2H → AcCH2CO−2 + H+

Unbound acetoacetate is primarily produced by liver mitochondria from its thioester with coenzyme A (CoA):

AcCH2C(O)−CoA + OH− → AcCH2CO−2 + H−CoA

The acetoacetyl-CoA itself is formed by three routes:

  • 3-hydroxy-3-methylglutaryl CoA releases acetyl CoA and acetoacetate:
    −O2CCH2−C(Me)(OH)−CH2C(O)−CoA → −O2CCH2−Ac + Ac−CoA
  • Acetoacetyl-CoA can come from beta oxidation of butyryl-CoA:
    Et−CH2C(O)−CoA + 2NAD+ + H2O + FAD → Ac−CH2C(O)−CoA + 2NADH + FADH2
  • Condensation of pair of acetyl CoA molecules as catalyzed by thiolase.[4]: 393 
    2Ac−CoA → AcCH2C(O)−CoA + H−CoA

In mammals, acetoacetate produced in the liver (along with the other two "ketone bodies") is released into the bloodstream as an energy source during periods of fasting, exercise, or as a result of type 1 diabetes mellitus.[5] First, a CoA group is enzymatically transferred to it from succinyl CoA, converting it back to acetoacetyl CoA; this is then broken into two acetyl CoA molecules by thiolase, and these then enter the citric acid cycle. Heart muscle and renal cortex prefer acetoacetate over glucose. The brain uses acetoacetate when glucose levels are low due to fasting or diabetes.[4]: 394 

Synthesis and properties

[edit]

Acetoacetic acid may be prepared by the hydrolysis of diketene. Its esters are produced analogously via reactions between diketene and alcohols,[3] and acetoacetic acid can be prepared by the hydrolysis of these species.[6] In general, acetoacetic acid is generated at 0 °C and used in situ immediately.[7]

It decomposes at a moderate reaction rate into acetone and carbon dioxide:

CH3C(O)CH2CO2H → CH3C(O)CH3 + CO2

The acid form has a half-life of 140 minutes at 37 °C in water, whereas the basic form (the anion) has a half-life of 130 hours. That is, it reacts about 55 times more slowly.[8] The corresponding decarboxylation of trifluoroacetoacetate is used to prepare trifluoroacetone:

CF3C(O)CH2CO2H → CF3C(O)CH3 + CO2

It is a weak acid (like most alkyl carboxylic acids), with a pKa of 3.58.

Acetoacetic acid displays keto-enol tautomerisation, with the enol form being partially stabilised by extended conjugation and intramolecular H-bonding. The equilibrium is strongly solvent depended; with the keto form dominating in polar solvents (98% in water) and the enol form accounting for 25-49% of material in non-polar solvents.[9]

Applications

[edit]
Pigment Yellow 16 is a typical dye containing the acetoacetyl group

Acetoacetic esters are used for the acetoacetylation reaction, which is widely used in the production of arylide yellows and diarylide dyes.[3] Although the esters can be used in this reaction, diketene also reacts with alcohols and amines to the corresponding acetoacetic acid derivatives in a process called acetoacetylation. An example is the reaction with 4-aminoindane:[10]

Diketene reaction Sai 2007

Detection

[edit]

Acetoacetic acid is measured in the urine of people with diabetes to test for ketoacidosis[11] and for monitoring people on a ketogenic or low-carbohydrate diet.[12][13] This is done using dipsticks coated in nitroprusside or similar reagents. Nitroprusside changes from pink to purple in the presence of acetoacetate, the conjugate base of acetoacetic acid, and the colour change is graded by eye. The test does not measure β-hydroxybutyrate, the most abundant ketone in the body; during treatment of ketoacidosis β-hydroxybutyrate is converted to acetoacetate so the test is not useful after treatment begins[11] and may be falsely low at diagnosis.[14]

Similar tests are used in dairy cows to test for ketosis.[15]

See also

[edit]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Acetoacetic acid

View on Grokipedia
from Grokipedia
Acetoacetic acid, also known as 3-oxobutanoic acid, is an with the molecular formula C₄H₆O₃ and the CH₃COCH₂COOH. It is the simplest beta-keto acid, characterized by a group beta to the , and exists primarily as its conjugate base acetoacetate at physiological due to stabilization. As one of the three principal ketone bodies—alongside beta-hydroxybutyrate and acetone—acetoacetic acid is synthesized in the liver mitochondria during ketogenesis from acetyl-CoA derived from fatty acid beta-oxidation, particularly under conditions of low glucose availability such as fasting or prolonged exercise. This process is regulated by hormones like glucagon, which promotes production, and insulin, which inhibits it. In extrahepatic tissues, including the brain and heart, acetoacetic acid serves as a critical alternative energy source, contributing 5–20% of total energy expenditure by being converted back to acetyl-CoA via succinyl-CoA:acetoacetate CoA transferase for entry into the citric acid cycle. Chemically, acetoacetic acid is unstable and undergoes spontaneous to form acetone and , especially in acidic conditions, which accounts for the fruity in cases of elevated levels. Its physical properties include a of 36.5 °C, and high (1000 mg/mL at 20 °C), with a pKa of approximately 3.58–3.59. Biologically, it plays roles beyond energy provision, acting as a precursor for synthesis (e.g., and phospholipids) and participating in pathways like and butyrate metabolism. Elevated levels of acetoacetic acid in or indicate , which can be physiological (e.g., during ketogenic diets) or pathological, as in where uncontrolled production leads to and metabolic crisis. Detection methods often measure concentrations, though acetoacetic acid levels can fluctuate due to its conversion to other ketones. Despite its experimental status in , its central role in metabolic underscores its importance in human physiology.

Chemical Properties

Structure and Tautomerism

Acetoacetic acid has the molecular formula C₄H₆O₃, commonly represented as CH₃COCH₂CO₂H. Its IUPAC name is 3-oxobutanoic acid. This compound is classified as a β-keto acid, featuring a group at the β-position relative to the functionality. The spatial arrangement of the β to the carboxyl allows for stabilization of the during , a process detailed in subsequent sections on stability. Acetoacetic acid exhibits keto-enol tautomerism, where the keto form (CH₃COCH₂CO₂H) interconverts with the enol form (CH₃C(OH)=CHCO₂H) via migration of the α-hydrogen and adjustment of the . The equilibrium strongly favors the keto tautomer, with approximately 98% keto form in at 35°C. This preference arises because polar solvents like stabilize the keto form through enhanced of the polar carbonyl and hydroxyl groups, shifting the equilibrium away from the less solvated enol. In less polar solvents, such as , the enol content increases to about 49%, due to intramolecular in the enol tautomer. The equilibrium can be represented as: CH3C(O)CH2CO2H⇌CH3C(OH)=CHCO2H\text{CH}_3\text{C(O)CH}_2\text{CO}_2\text{H} \rightleftharpoons \text{CH}_3\text{C(OH)=CHCO}_2\text{H} Acetoacetic acid lacks chiral centers, as none of its carbon atoms bear four different substituents, resulting in no optical activity.

Physical and Chemical Properties

Acetoacetic acid appears as a colorless solid at , with a of 36.5 °C. It has a of 1.07 g/cm³ at 25 °C. The compound is highly soluble in , with a exceeding 1,000 g/L at 20 °C, and is miscible with common organic solvents such as . Acetoacetic acid decomposes upon heating and does not have a well-defined under standard conditions, though estimates place it around 237–239 °C at 760 mm Hg pressure. As a weak organic acid, acetoacetic acid undergoes dissociation in aqueous solution according to the equilibrium: CH3COCH2COOH⇌CH3COCH2COO−+H+\mathrm{CH_3COCH_2COOH \rightleftharpoons CH_3COCH_2COO^- + H^+} Its acidity is characterized by a pKa value of 3.59 at 0 °C, indicating moderate acidity typical of β-keto carboxylic acids. Spectroscopic analysis provides key insights into its structure. In the ¹H NMR spectrum (500 MHz, D₂O, pH 7), the methyl group (CH₃) appears at approximately 2.27 ppm, and the methylene group (CH₂) at 3.44 ppm; the carboxylic proton signal is not observed under neutral conditions due to rapid exchange. The ¹³C NMR spectrum (125 MHz, D₂O, pH 7) shows signals at 32.27 ppm (CH₃), 56.05 ppm (CH₂), 177.38 ppm (CO₂⁻), and 212.85 ppm (C=O). Infrared spectroscopy reveals characteristic absorptions for the carbonyl groups, with the ketone C=O stretch around 1720 cm⁻¹ and the carboxylic acid C=O around 1710 cm⁻¹, though exact values depend on the enol-keto equilibrium influenced by tautomerism.

Stability and Reactivity

Acetoacetic acid exhibits notable thermal instability characteristic of β-keto acids, undergoing spontaneous to yield acetone and . The decomposition follows \ceCH3COCH2CO2H−>CH3COCH3+CO2\ce{CH3COCH2CO2H -> CH3COCH3 + CO2} This process involves a concerted mechanism where the form of the adjacent carbonyl facilitates the loss of CO₂ through a cyclic . Kinetic studies reveal that the of the neutral acid form is approximately 140 minutes at 37°C in , reflecting its rapid breakdown under physiological conditions. In contrast, the conjugate base, acetoacetate anion, demonstrates substantially greater stability with a of around 130 hours at the same . The rate of decarboxylation is accelerated by elevated temperatures and acidic environments, as enhances the reactivity of the carboxyl group. The presence of an enolizable α-hydrogen positioned between the and carboxyl carbonyls confers high reactivity to acetoacetic acid, enabling to form an under basic conditions. This is nucleophilic and participates in reactions with aldehydes or other s, forming β-hydroxy carbonyl products that may further dehydrate. Additionally, the carbonyl groups themselves react with nucleophiles, such as in esterification or amidation, though the instability often limits practical handling. Due to its short and propensity for gas evolution during , acetoacetic acid poses handling challenges and is generally prepared in dilute solutions or to mitigate risks associated with rapid breakdown.

Synthesis

Historical Methods

Acetoacetic acid was first identified in 1865 by the German chemist Carl Gerhardt in the urine of patients with mellitus, recognizing it as a key precursor to acetone through its reaction with ferric chloride, which produces a characteristic violet color. This finding marked an early step in elucidating the chemical basis of , a hallmark of severe where elevated like acetoacetic acid accumulated, signaling metabolic crisis and coma risk in cases before 1900. The first laboratory synthesis of acetoacetic acid occurred in 1882, achieved by American chemist Beverly S. Burton in , , via the hydrolysis of propyl acetoacetate derivatives prepared from and propyl iodide. Burton's work built on prior observations of acetoacetic esters, highlighting the compound's tendency to decarboxylate spontaneously to acetone during isolation attempts. Subsequent early methods centered on hydrolyzing acetoacetic esters under acidic or basic conditions to yield the free acid, with ethyl acetoacetate—synthesized through the Claisen condensation of ethyl acetate in the presence of sodium ethoxide—serving as a primary precursor. In the 1910s, the Weizmann fermentation process emerged as a biological route for acetone production, employing the bacterium Clostridium acetobutylicum to break down starchy substrates into intermediates including acetoacetic acid, which then decarboxylated to acetone; this method supported industrial acetone needs during World War I without directly isolating the acid.

Modern Preparation Techniques

The primary modern laboratory and industrial method for preparing acetoacetic acid involves the of with water or a base, generating the acid in situ at low temperatures around 0°C to prevent rapid and decomposition. itself is produced on an industrial scale through the thermal dimerization of , which is obtained via high-temperature of acetic acid, enabling efficient, large-scale production at facilities equipped for handling reactive intermediates. This proceeds quantitatively under controlled neutral or basic aqueous conditions at 15–35°C, as confirmed by pH-stat and UV-vis , though practical yields are typically 80–90% when accounting for handling losses and instability. Due to the instability of free acetoacetic acid, which decarboxylates readily above °C, the process is often adapted for ester production by reacting directly with alcohols in the presence of an acid catalyst, affording stable acetoacetic s in 93% yield after . This variant is widely used industrially for scalable synthesis, with 's on-site generation ensuring safety and efficiency in multipurpose plants. Alternative chemical routes include the oxidation of 3-hydroxybutyric acid using as an oxidant, providing spectral evidence for clean conversion to acetoacetic acid under mild conditions. Another approach involves the of acetone, typically via or related catalytic processes, though it is less commonly employed due to the availability of the method. Enzymatic synthesis analogs, such as the of acetoacetyl-CoA by acetoacetyl-CoA (EC 3.1.2.11), offer a biocatalytic parallel for generating acetoacetate from precursors in aqueous media.

Biochemical Role

Biosynthesis in the Liver

Acetoacetic acid, also known as acetoacetate, is synthesized in the liver as part of the pathway, which is activated during periods of or low carbohydrate availability. Under these conditions, in releases free fatty acids that are transported to the liver and undergo β-oxidation in the mitochondria, producing excess that cannot enter the tricarboxylic acid cycle due to limited oxaloacetate availability. This is then diverted into to generate , including acetoacetate, for export to extrahepatic tissues as an alternative energy source. The ketogenesis pathway occurs exclusively in the mitochondria of hepatocytes and involves three key enzymatic steps. First, two molecules of acetyl-CoA condense to form acetoacetyl-CoA, catalyzed by the enzyme thiolase (also known as acetyl-CoA acetyltransferase 1, ACAT1). This reaction is reversible and represented as: 2 CH3COSCoA⇌ CH3COCH2COSCoA+CoASH2 \text{ CH}_3\text{COSCoA} \rightleftharpoons \text{ CH}_3\text{COCH}_2\text{COSCoA} + \text{CoASH} Next, acetoacetyl-CoA combines with another acetyl-CoA to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), the rate-limiting step catalyzed by HMG-CoA synthase (HMGCS2). Finally, HMG-CoA is cleaved by HMG-CoA lyase (HMGCL) to yield acetoacetate and free acetyl-CoA, completing the biosynthesis of the primary ketone body. Due to the high NADH/NAD⁺ ratio in liver mitochondria during β-oxidation, much of the acetoacetate is then reduced to β-hydroxybutyrate by β-hydroxybutyrate dehydrogenase, with β-hydroxybutyrate being the predominant ketone body exported to the circulation. These mitochondrial enzymes ensure efficient production without the involvement of cytosolic pathways. Ketogenesis is tightly regulated to match physiological energy demands, primarily through hormonal signals. , elevated during , upregulates the pathway by promoting via activation of hormone-sensitive and enhancing oxidation, while also inducing expression of HMGCS2 through transcription factors like PPARα. In contrast, insulin, predominant in the fed state, suppresses ketogenesis by inhibiting , increasing levels (which block carnitine palmitoyltransferase-1 and entry into mitochondria), and repressing HMGCS2 activity via post-translational modifications such as succinylation. This reciprocal hormonal control prevents excessive ketone production under normal conditions.

Metabolism and Utilization

Acetoacetic acid, also known as acetoacetate, serves as a key energy substrate in extrahepatic tissues, where it is activated and metabolized to generate ATP through the tricarboxylic acid (TCA) cycle. Since β-hydroxybutyrate is the predominant circulating ketone body, it is first oxidized to acetoacetate in the mitochondria by β-hydroxybutyrate dehydrogenase, using NAD⁺ as a cofactor. The subsequent activation step involves the enzyme succinyl-CoA:3-ketoacid CoA-transferase (SCOT), which catalyzes the transfer of the CoA moiety from to acetoacetate, forming acetoacetyl-CoA and succinate. This reaction is essential for ketone body utilization and occurs primarily in the mitochondria of non-hepatic tissues. The activation can be represented as: CH3COCH2CO2−+CoAS-Suc→CH3COCH2COSCoA+Suc2−\text{CH}_3\text{COCH}_2\text{CO}_2^- + \text{CoAS-Suc} \rightarrow \text{CH}_3\text{COCH}_2\text{COSCoA} + \text{Suc}^{2-} Subsequently, acetoacetyl-CoA is cleaved by mitochondrial acetoacetyl-CoA (ACAT1) into two molecules of in the presence of (CoASH), allowing the to enter the TCA cycle for and ATP production. This cleavage reaction is: Acetoacetyl-CoA+CoASH→2 acetyl-CoA\text{Acetoacetyl-CoA} + \text{CoASH} \rightarrow 2 \text{ acetyl-CoA} Ketone body utilization, including acetoacetate metabolism, is highly expressed in tissues such as the heart, brain, and kidney, where SCOT and thiolase activities support efficient energy derivation from ketones. In the brain, during prolonged starvation, ketone bodies can provide up to 60-70% of the organ's energy requirements after metabolic adaptation, reducing reliance on glucose. The interconversion between acetoacetate and β-hydroxybutyrate is reversible via β-hydroxybutyrate dehydrogenase and depends on the cellular redox state (NADH/NAD⁺ ratio), with peripheral tissues generally favoring oxidation of β-hydroxybutyrate to acetoacetate to support energy production.

Physiological and Medical Significance

Role in Ketosis and Ketoacidosis

Acetoacetic acid plays a central role in physiological , a adaptive state induced by , prolonged exercise, or restriction, where it serves as an alternative energy source to spare glucose for glucose-dependent tissues like the . In this process, the liver produces acetoacetic acid via from fatty acids, which is then released into the bloodstream for utilization by extrahepatic tissues. During normal , blood levels of , including acetoacetic acid, typically range from 0.5 to 3.0 mM, reflecting a controlled elevation that supports metabolic efficiency without causing . In contrast, acetoacetic acid contributes to the pathological state of (DKA), primarily in due to absolute insulin deficiency, which promotes unchecked and hepatic . This leads to excessive accumulation of acetoacetic acid and other ketones, resulting in with blood pH often below 7.3 and exceeding 12 mM. Acetoacetic acid, as a strong , dissociates to release ions, exacerbating the and contributing significantly to the elevated observed in DKA. DKA manifests with symptoms such as fruity breath from acetone derived from acetoacetic acid, due to osmotic , and potentially from severe and imbalances; it occurs in approximately 38-40% of new diagnoses in the United States. Acetoacetic acid equilibrates with β-hydroxybutyrate via β-hydroxybutyrate , with the β-hydroxybutyrate:acetoacetic acid ratio shifting from a normal 1:1 to as high as 10:1 in DKA due to elevated NADH/NAD+ ratios favoring reduction. Additionally, acetoacetic acid undergoes spontaneous to acetone, which constitutes about 2-5% of total ketones in DKA, contributing to the characteristic breath but playing a minor role in .

Therapeutic Potential and Recent Research

Acetoacetic acid, as an , has shown promise in managing by exerting antiseizure effects through modulation of neuronal excitability and composition. Studies indicate that supplementation with acetoacetate-containing ketone esters reduces frequency and severity in preclinical models, potentially offering an alternative to traditional ketogenic diets that are challenging for long-term adherence. For , including acetoacetate provide by enhancing cerebral energy metabolism and mitigating , though direct HDAC inhibition is more prominently associated with β-hydroxybutyrate; acetoacetate contributes indirectly via ketone body interconversion. In athletic performance, exogenous acetoacetate supplementation elevates circulating levels, which may improve endurance by sparing and altering metabolism, with some trials reporting enhanced recovery despite mixed outcomes on peak performance metrics. Recent research from 2023 demonstrated that acetoacetate inhibits mast cell degranulation, thereby attenuating anaphylactic reactions in vivo and suggesting a role in allergy treatment by suppressing inflammatory mediator release. In 2024, positron emission tomography (PET) imaging studies revealed distinct uptake kinetics of radiolabeled acetoacetate in the brain and heart of rodents under varying ketone conditions, highlighting its potential for non-invasive assessment of tissue-specific ketone utilization in metabolic disorders. By 2025, investigations linked impaired ketogenesis and reduced acetoacetate levels in Leydig cells to testicular aging, with restoration of ketone production reversing senescence markers and improving testosterone synthesis, proposing ketone supplementation as a therapeutic strategy for age-related reproductive decline. Within ketogenic diets, acetoacetic acid serves as a key monitorable ketone for weight loss interventions, where elevated levels indicate nutritional ketosis and support fat oxidation, though challenges arise from variable conversion to β-hydroxybutyrate, affecting efficacy. As an adjunct to cancer therapy, ketogenic diets inducing acetoacetate production sensitize tumors to chemotherapy and radiation by exploiting cancer cells' glucose dependency, with preclinical evidence showing suppressed colorectal tumor growth via microbiome alterations. Ongoing clinical trials explore exogenous acetoacetate supplements for neurodegeneration, including modulation of insulin secretion in mild cognitive impairment models to enhance β-cell function and cerebral glucose utilization. These efforts underscore acetoacetate's evolving role, distinct from ketoacidosis risks, in targeted metabolic therapies.

Applications

Industrial Uses

Acetoacetic acid derivatives, particularly its esters and amides such as acetoacetanilides, play a significant role in the production of organic used in dyes. The acetoacetylation process involves reacting acetoacetic acid derivatives with arylamines or arylides to form coupling components that are then used in reactions. For instance, acetoacetylation of o-toluidine derivatives yields intermediates essential for synthesizing Pigment Yellow 16, a diarylide pigment valued for its bright color and stability in inks and coatings. Similarly, diarylide pigments, including various and orange shades, are manufactured by tetrazotizing derivatives and coupling them with acetoacetanilides derived from acetoacetic acid, enabling high-volume production for and industrial applications. These pigments are prized for their cost-effectiveness and , with acetoacetanilides providing the reactive β-ketoester functionality that enhances color intensity. In polymer and coating industries, acetoacetic acid serves as an intermediate through its ester derivatives, which introduce dynamic acetoacetyl groups into polymer backbones. Ethyl acetoacetate, for example, reacts with isocyanates to form acetoacetyl-formed amides, enabling the creation of reprocessable foams with improved mechanical recyclability and thermal stability. These derivatives are also incorporated into adhesives, where acetoacetate end-capped polyols facilitate isocyanate-free polyurethane formulations, yielding s and elastomers with enhanced adhesion to substrates like wood and metal without volatile organic compounds. Such applications leverage the enolizable nature of acetoacetyl groups for cross-linking, resulting in durable materials used in automotive and sectors. Acetoacetic acid esters, notably , act as versatile precursors in pharmaceutical synthesis, particularly for analgesics and related compounds. Through the acetoacetic ester synthesis, undergoes and to produce substituted methyl ketones, which serve as building blocks for non-steroidal drugs and other analgesics. This method has been widely adopted for synthesizing intermediates in analgesics like those derived from or scaffolds, highlighting its utility in scalable drug production.

Derivatives and Esters

Acetoacetic acid, being prone to spontaneous , is unstable under normal conditions, necessitating the use of its derivatives such as esters for practical storage and applications. These esters, particularly the ethyl and methyl variants, serve as stable proxies that retain the β-keto acid functionality while exhibiting enhanced thermal stability. The primary esters of acetoacetic acid are synthesized via alcoholysis of , a process that involves the reaction of with the corresponding alcohol, such as for (CH₃COCH₂CO₂CH₂CH₃) or for methyl acetoacetate. This method achieves high yields, often exceeding 95%, making it industrially viable. , for instance, boils at approximately 180°C, allowing for safe and long-term storage without significant decomposition. These β-ketoesters are valued for their reactivity, particularly at the α-position, where formation enables reactions central to synthetic . finds specific use in perfumery due to its fruity odor and as a key intermediate in reactions for building complex carbon skeletons. Methyl acetoacetate shares analogous properties and applications, serving similarly as a versatile synthetic building block. Beyond esters, other notable derivatives include acetoacetanilides, which are prepared by amidation of acetoacetic acid or its equivalents and are employed in the production of azo pigments for their coupling reactivity.

Detection and Analysis

Clinical Detection Methods

The primary clinical detection method for acetoacetic acid, also known as acetoacetate, involves the nitroprusside test, a colorimetric reaction commonly performed using urine dipsticks. In this test, reacts with acetoacetate in the presence of and to produce a pink-to-purple color, with the intensity proportional to the concentration; detection sensitivity is approximately 0.5 to 5 mmol/L (5 to 50 mg/dL), allowing semi-quantitative assessment from trace to large amounts. This bedside test is widely used for screening (DKA) in patients with and for monitoring adherence to ketogenic diets, where elevated acetoacetate levels indicate . Despite its convenience, the nitroprusside test has notable limitations, as it primarily detects acetoacetate and acetone but is insensitive to β-hydroxybutyrate, the predominant ketone body in DKA, potentially underestimating overall ketonemia severity. Additionally, false-positive results can occur due to interference from sulfhydryl-containing compounds, such as , , or , which react directly with nitroprusside to mimic the color change. These shortcomings necessitate complementary testing, such as direct β-hydroxybutyrate measurement, for accurate DKA management. In , similar nitroprusside-based tests are employed to detect acetoacetate in or from dairy cows to diagnose , a common postpartum characterized by elevated . These cow-side strip tests provide rapid qualitative results, enabling early intervention to prevent milk yield loss and secondary complications like ; for instance, ketone levels above 1.5 mmol/L (15 mg/dL) often signal subclinical . Blood tests are preferred for precision, but and assays remain practical for on-farm screening due to their ease of use. Point-of-care blood ketone testing for acetoacetate can be performed using nitroprusside-based reagents adapted for , though such methods are less common than enzymatic assays for β-hydroxybutyrate; these provide rapid results in clinical settings like emergency departments for DKA evaluation, with detection thresholds similar to urine tests (around 0.5 mmol/L). Handheld meters employing nitroprusside reactions offer portability but share the same limitations regarding β-hydroxybutyrate insensitivity and potential interferences.

Laboratory Analytical Techniques

High-performance liquid chromatography (HPLC) coupled with (UV) detection is a widely used technique for quantifying acetoacetic acid in biological samples such as plasma and , offering high precision and the ability to separate it from structurally similar s like β-hydroxybutyrate. In typical setups, samples are deproteinized and injected onto a reversed-phase C18 column, with a mobile phase of phosphate buffer and enabling separation; detection occurs at wavelengths around 254 nm due to the carbonyl absorption, though post-column derivatization with agents like p-nitrobenzene diazonium fluoroborate can shift detection to 645 nm for enhanced sensitivity in serum and analysis. This method achieves a limit of detection (LOD) as low as 2.1 μM and is particularly valuable in for body profiling, where accurate differentiation from β-hydroxybutyrate is essential via enzymatic pre-treatment or optimized gradients. Gas chromatography-mass spectrometry (GC-MS) provides confirmatory analysis for acetoacetic acid, especially in derivatized forms to improve volatility and stability for complex biological matrices. Derivatization commonly involves with agents like N-methyl-N-(t-butyldimethylsilyl)trifluoroacetamide or pentafluorobenzyl bromide to convert the and keto groups into more GC-friendly derivatives, followed by separation on a non-polar column and identification via impact . This approach excels in trace-level quantification and structural elucidation, with applications in metabolomic studies of profiles in plasma. Enzymatic assays offer a specific and straightforward means for indirect of acetoacetic acid through the reversible action of 3-hydroxybutyrate dehydrogenase (HBDH), which catalyzes the reduction of acetoacetic acid to β-hydroxybutyrate using NADH as a cofactor, monitored by the decrease in NADH at 340 nm. These assays are adaptable to spectrophotometric or fluorometric formats and are suitable for plasma, serum, and samples, with commercial kits providing reproducible results over a linear range of 0.01–2.5 mM. For colorimetric endpoints, enzymatic kits employ HBDH in conjunction with chromogenic substrates to produce measurable color changes proportional to acetoacetic acid concentration, enhancing accessibility in settings. Nuclear magnetic resonance (NMR) spectroscopy serves as a powerful tool for structural confirmation of acetoacetic acid in purified samples or complex mixtures, providing detailed proton and carbon data without the need for derivatization. In 1H NMR at 500 MHz in aqueous media, characteristic signals include the methyl protons at approximately 1.4 ppm (doublet) and 2.2 ppm (singlet), alongside the enol and keto tautomer peaks, confirming the β-keto acid structure with high resolution. This technique is particularly useful in research for validating acetoacetic acid identity during ketone profiling studies. Advanced variants like liquid chromatography-tandem (LC-MS/MS) extend HPLC capabilities with pre-column derivatization using O-(2,3,4,5,6-pentafluorobenzyl), achieving a lower limit of quantification of 0.10 μM in rat plasma and supporting comprehensive analysis in biological . Recent advances as of 2025 include electrochemical sensors for simultaneous detection of acetoacetate and acetone in breath or urine, and microfluidic paper-based devices for acetoacetate in artificial urine, enhancing point-of-care and low-cost options. While nitroprusside-based tests provide a simple qualitative screen for acetoacetic acid in clinical contexts, laboratory techniques prioritize quantitative precision for investigative purposes.

References

  1. https://hmdb.ca/metabolites/HMDB0000060
  2. https://go.drugbank.com/drugs/DB01762
  3. https://www.sciencedirect.com/topics/nursing-and-health-professions/acetoacetic-acid
  4. https://www.ncbi.nlm.nih.gov/books/NBK554523/
  5. https://pubchem.ncbi.nlm.nih.gov/compound/Acetoacetic-Acid
  6. https://pubs.acs.org/doi/10.1021/acs.jpcc.0c10797
  7. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4ZI204Y1MC
  8. https://commonchemistry.cas.org/detail?cas_rn=541-50-4
  9. https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_(Morsch_et_al.)/20%3A_Carboxylic_Acids_and_Nitriles/20.05%3A_Spectroscopy_of_Carboxylic_Acids_and_Nitriles
  10. https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_(Morsch_et_al.)/23%3A_Carbonyl_Condensation_Reactions/23.03%3A_Aldol_Addition
  11. https://litfl.com/carl-gerhardt/
  12. https://www.cambridge.org/core/services/aop-cambridge-core/content/view/81918D6B04EF3CE85E33511BFB11C5C7/S0029665190000441a.pdf/ketone_bodies_as_substrates.pdf
  13. https://diabetesjournals.org/care/article/37/11/3124/29226/Hyperosmolar-Hyperglycemic-State-A-Historic-Review
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC4207202/
  15. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/acetoacetic-acid
  16. https://www.sciencedirect.com/topics/medicine-and-dentistry/acetoacetic-acid
  17. https://www.masterorganicchemistry.com/2020/09/14/claisen-condensation-and-dieckmann-condensation/
  18. https://www.sciencedirect.com/topics/chemistry/acetoacetic-acid
  19. https://portlandpress.com/biochemj/article/37/2/230/43815/Studies-on-the-acetone-butanol-fermentation4
  20. https://patents.google.com/patent/US5484949A/en
  21. https://www.arxada.com/content/dam/arxada/SPS/CDMO/white-papers/202307_Whitepaper_QuickAccesstoUbiquitousMoieties_DiketeneasaVersatileDoorOpenerforAcetoacetatesandFurther1_3_substitutionPatterns_digital.pdf
  22. https://alquilnitrosos.usal.es/papers/CRT200821.pdf
  23. https://patents.google.com/patent/US3117156A/en
  24. https://pubmed.ncbi.nlm.nih.gov/1294466/
  25. https://iubmb.qmul.ac.uk/enzyme/EC3/1/2/11.html
  26. https://www.ncbi.nlm.nih.gov/books/NBK493179/
  27. https://doi.org/10.3390/ijms17122093
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC6260335/
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC5187893/
  30. https://pubmed.ncbi.nlm.nih.gov/9380443/
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC3219306/
  32. https://journals.physiology.org/doi/10.1152/ajpendo.00454.2019
  33. https://www.ncbi.nlm.nih.gov/books/NBK560723/
  34. https://diabetesjournals.org/care/article/47/8/1257/156808/Hyperglycemic-Crises-in-Adults-With-Diabetes-A
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC151994/
  36. https://www.mayoclinic.org/diseases-conditions/diabetic-ketoacidosis/symptoms-causes/syc-20371551
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC8323183/
  38. https://pubmed.ncbi.nlm.nih.gov/10634967/
  39. https://www.mayocliniclabs.com/test-catalog/download-setup?format=pdf&unit_code=9251
  40. https://onlinelibrary.wiley.com/doi/10.1111/epi.18150
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC12388514/
  42. https://pubmed.ncbi.nlm.nih.gov/36214993/
  43. https://www.researchgate.net/publication/374235521_Ketone_bodies_inhibit_mast_cell_degradation_and_protect_against_anaphylaxis
  44. https://pubmed.ncbi.nlm.nih.gov/39476467/
  45. https://www.nature.com/articles/s41467-025-59591-8
  46. https://www.nature.com/articles/s41467-025-56678-0
  47. https://academic.oup.com/jes/article/9/8/bvaf101/8157061
  48. https://clinicaltrials.gov/study/NCT04466735
  49. https://patents.google.com/patent/WO2009129455A2/en
  50. https://patents.google.com/patent/US20110061564A1/en
  51. https://www.sciencedirect.com/science/article/abs/pii/S0143720800000899
  52. https://pubs.acs.org/doi/abs/10.1021/acsami.3c12132
  53. https://patents.google.com/patent/JP2024511116A/en
  54. https://www.sciencedirect.com/science/article/abs/pii/S0040402010011786
  55. https://www.chemicalbook.com/synthesis/ethyl-acetoacetate.htm
  56. https://pubchem.ncbi.nlm.nih.gov/compound/Ethyl-Acetoacetate
  57. https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_%28OpenStax%29/22%253A_Carbonyl_Alpha-Substitution_Reactions/22.07%253A_Alkylation_of_Enolate_Ions
  58. https://pubchem.ncbi.nlm.nih.gov/compound/Methyl-acetoacetate
  59. https://www.chemicalbook.com/ChemicalProductProperty_EN_CB0463919.htm
  60. https://www.ncbi.nlm.nih.gov/books/NBK247/
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC5734222/
  62. https://jamanetwork.com/journals/jama/fullarticle/404986
  63. https://www.merckvetmanual.com/metabolic-disorders/hyperketonemia-in-cattle/hyperketonemia-in-cattle
  64. https://emedicine.medscape.com/article/2087982-overview
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC8897555/
  66. https://www.mdpi.com/1660-4601/17/17/6158
  67. https://pubmed.ncbi.nlm.nih.gov/12673014/
  68. https://louis.uah.edu/cgi/viewcontent.cgi?article=1704&context=uah-theses
  69. https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/402/575/mak134bul.pdf
  70. https://www.arigobio.com/download/protocols?file=ARG82173-Ketone-Body-Assay-Kit-Colorimetric-User-manual-210708.pdf&product_sn=20395
  71. https://hmdb.ca/spectra/nmr_one_d/1060
  72. https://www.jstage.jst.go.jp/article/jpchrom/35/3/35_2014.017/_pdf
  73. https://www.sciencedirect.com/science/article/pii/S0925400525003326
  74. https://www.researchgate.net/publication/387175276_Simultaneous_Detection_of_Glucose_and_Acetoacetate_in_Artificial_Urine_Samples_Using_3D-Connector_Microfluidic_Paper_Based_Analytical_DevicesEnglish
  75. https://www.abcam.com/en-us/products/assay-kits/acetoacetate-assay-kit-colorimetric-ab180875
Add your contribution
Related Hubs
User Avatar
No comments yet.